CBIO
Price:
$10.9
Market Cap:
$300.37M
Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates. Its pipeline includes CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company has a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. for the development and commercialization of oncology therapeutics, including novel combinations. The company is headquartered in Waltham, Massachusetts.
Industry
Biotechnology
IPO Date
2014-01-10
Stock Exchange
NASDAQ
Ticker
CBIO
According to Crescent Biopharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -122.12%. This represents a change of 222.02% compared to the average of -37.92% of the last 4 quarters.
The mean historical ROE of Crescent Biopharma, Inc. over the last ten years is -191.77%. The current -122.12% ROE has changed -36.32% with respect to the historical average. Over the past ten years (40 quarters), CBIO's ROE was at its highest in in the March 2018 quarter at -4.84%. The ROE was at its lowest in in the December 2024 quarter at -135.93%.
Average
-191.77%
Median
-75.79%
Minimum
-1345.01%
Maximum
-23.50%
Discovering the peaks and valleys of Crescent Biopharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.30%
Maximum Annual ROE = -23.50%
Minimum Annual Increase = -94.51%
Minimum Annual ROE = -1345.01%
| Year | ROE | Change |
|---|---|---|
| 2025 | -73.86% | -94.51% |
| 2024 | -1345.01% | 1.30% |
| 2023 | -96.06% | -11.68% |
| 2022 | -108.76% | 39.92% |
| 2021 | -77.73% | 95.31% |
| 2020 | -39.80% | 13.40% |
| 2019 | -35.09% | 49.37% |
| 2018 | -23.50% | -15.50% |
| 2017 | -27.80% | -69.15% |
| 2016 | -90.11% | 185.60% |
The current ROE of Crescent Biopharma, Inc. (CBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-504.98%
5-year avg
-340.28%
10-year avg
-191.77%
Crescent Biopharma, Inc.’s ROE is less than Compugen Ltd. (55.68%), greater than C4 Therapeutics, Inc. (-53.83%), greater than Sangamo Therapeutics, Inc. (-813.95%), less than Insight Molecular Diagnostics Inc. (2.39%), less than Armata Pharmaceuticals, Inc. (70.29%), greater than Tonix Pharmaceuticals Holding Corp. (-60.15%), greater than Vyome Holdings, Inc. (-364.96%), less than Heron Therapeutics, Inc. (304.91%), greater than Innate Pharma S.A. (-658.91%), greater than OmniAb, Inc. (-23.99%),
| Company | ROE | Market cap |
|---|---|---|
| 55.68% | $197.62M | |
| -53.83% | $223.63M | |
| -813.95% | $123.29M | |
| 2.39% | $122.19M | |
| 70.29% | $305.45M | |
| -60.15% | $201.08M | |
| -364.96% | $12.87M | |
| 304.91% | $122.97M | |
| -658.91% | $109.68M | |
| -23.99% | $199.18M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Crescent Biopharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Crescent Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Crescent Biopharma, Inc.'s ROE?
How is the ROE calculated for Crescent Biopharma, Inc. (CBIO)?
What is the highest ROE for Crescent Biopharma, Inc. (CBIO)?
What is the 3-year average ROE for Crescent Biopharma, Inc. (CBIO)?
What is the 5-year average ROE for Crescent Biopharma, Inc. (CBIO)?
How does the current ROE for Crescent Biopharma, Inc. (CBIO) compare to its historical average?